A clinical comparison of interventional strategies of PVCE and TACE on hepatic metastasis from colorectal cancer

doi:10.3877/cma.j.issn.2095-5782.2016.04.001

Abstract

Abstract:

Objective:

To study the therapeutic effect, survival time and complications of transcatheter portal vein chemoembolization (PVCE) in the treatment of liver metastases from colorectal cancer.

Methods:

80 cases of colorectal cancer with pathologically confirmed liver metastases were collected and randomly divided into two groups. In the treatment group, 40 patients underwent PVCE while in the control group 40 patients underwent TACE.

Results:

The rate of CR+PR is 82.5% in PVCE group and 55.0% in TACE group. It also showed a statistical significance of t 6, 12, and 24 months survivals as 92.5%, 62.5% and 40.0% in PVCE group, while that in the TACE group were 75.0%, 52.5% and 22.5%, respectively.

Conclusions:

In treating hepatic metastasis from colorectal cancer, the PVCE has a better therapeutic effect with a higher survival rate and longer survival time in comparison with TACE.

Key words: Colorectal neoplasms, Hepatic metastasis, PVCE, TACE

Xikun Zhang, Zhongfa Xu, Huangang Yang, Hongxin Niu, Dewen Xue, Bin Wang, Lin Sun. A clinical comparison of interventional strategies of PVCE and TACE on hepatic metastasis from colorectal cancer[J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2016, 04(04): 189-191.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhjrfsxdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-5782.2016.04.001

https://zhjrfsxdzzz.cma-cmc.com.cn/EN/Y2016/V04/I04/189

Figures/Tables 1

References 11

1	van der Stok EP, Grünhagen DJ, Alberda WJ,et al. The prognostic value of the primary tumor's nodal status after surgery for colorectal liver metastases in the era of effective systemic therapy[J]. Dig Surg, 2015,32(3):208-216. doi: 10.1159/000381755.
2	Donati M, Stavrou GA, Stang A, et al. 'Liver-first' approach for metastatic colorectal cancer[J].Future Oncol, 2015,11(8):1233-1243. doi: 10.2217/fon.14.316.
3	Hamadani M. Autologous hematopoietic cell transplantation: an update for clinicians[J].Ann Med, 2014 ,46(8):619-632. doi: 10.3109/07853890.2014.952662.
4	邵永孚.胃肠道癌肝转移瘤的治疗[J].中华胃肠外科杂志,2005,8(1):5-6.doi:10.3760/cma.j.issn.1671-0274.2005.01.001.
5	Wu YP, Zhang WZ, Li L,et al. Comparison of therapeutic effects between transcatheter arterial chemoembolization and transcatheter arterial-portal venous double chemoembolization in tret alment of moderate and advanced stages of primary liver carcinoma[J]. Ai Zheng,2003 ,22(8):880-883.
6	Kinoshita F. Hepatic scintigram. 6. Metastatic cancer of the liver[J]. RinshoHoshasen, 1971, 16(10):871-872.
7	唐代荣. 肝转移瘤的CT双期扫描诊断[J]. 中华临床医师杂志(电子版), 2010,4(1):98-100.doi:10.3969/j.issn.1674-0785.2010.01.022.
8	李智岗, 时高峰, 黄景香.应用DSA、CT和经肠系膜上动脉门静脉灌注CT成像研究肝转移瘤的血液供应[J]. 中华放射学杂志，2008,42(9) :949-953. doi:10.3321/j.issn:1005-1201.2008.09.013.
9	苗成利,王乃利. ,夏晓飞, 等. 结直肠癌肝脏转移瘤微血管形态的变化[J].中华肝胆外科杂志，2014，20(6):418-421.doi:10.3760/cma.j.issn.1007-8118.2014.06.006.
10	周大勇, 王建华, 钱晟, 等. 肝动脉化疗栓塞术对富血供肝转移瘤的疗效分析[J].介入放射学杂志, 2007, 16(3):165-167. doi:10.3969/j.issn.1008-794X.2007.03.007.
11	Isenberg J, Fischbach R, Krüger I,et al. Treatment of liver metastases from colorectal cancer[J]. Anticancer Res, 1996, 16(3A): 1291-1295.

组别	例数	CR(例)	PR(例)	NC(例)	PD(例)	临床有效[例(%)]	χ²值	P值
PVCE组	40	9	24	6	1	33（82.5）	7.040	0.008
TACE组	40	4	18	14	4	22（55.0）	?	?

组别	例数	CR(例)	PR(例)	NC(例)	PD(例)	临床有效[例(%)]	χ²值	P值
PVCE组	40	9	24	6	1	33（82.5）	7.040	0.008
TACE组	40	4	18	14	4	22（55.0）	?	?

[1]	Xia Kang, Hao Tian, Jin Qian, Yuan Gao, Hongming Miao, Xiaowei Qi. Osteorin attenuates osteolysis during bone metastasis of cancers through inhibiting osteoclastogenesis [J]. Chinese Journal of Breast Disease(Electronic Edition), 2023, 17(06): 329-339.
[2]	Dechen Wang, Kang Yang, Zijie Yang, Mingbin Gui, Lianping Qu, Xiaofeng Zhang, Feng Gao. Progress of microsatellite stability state and PD-1/PD-L1/IDO in colorectal carcinoma [J]. Chinese Archives of General Surgery(Electronic Edition), 2023, 17(06): 462-465.
[3]	Jia Fu, Haimin Xiao, Xi Wu, Tao Feng, Shuai Shi. Value of age-adjusted Charlson comorbidity index in assessing perioperative complications for laparoscopic colorectal cancer [J]. Chinese Archives of General Surgery(Electronic Edition), 2023, 17(05): 336-341.
[4]	Yongting Xue, Feng Gao, Yanan Wang, Lianping Qu. Application of oncolytic virus therapy in colorectal cancer [J]. Chinese Archives of General Surgery(Electronic Edition), 2023, 17(05): 380-384.
[5]	Huiming Wu, Renkai Guo, Huiyu Li. Safety and efficacy of robot-assisted natural orifice specimen extraction surgery for colorectal cancer: A meta-analysis [J]. Chinese Archives of General Surgery(Electronic Edition), 2023, 17(05): 395-400.
[6]	Xu Tang, Bing Han, Wei Liu, Ruxing Chen. Analysis of risk factors for metachronous liver metastases after radical colorectal cancer surgery and construction of a predictive model [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 16-20.
[7]	Shengjun Zhang, Ajing Zhao, Shoubo Li, Xianghong Hao, Minli Liu. An experimental study on the promotion of colorectal cancer invasion and migration by high glucose through HGF/c-met pathway [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 21-24.
[8]	Ting Li, Lin Zhang. Relationship between serum fatty acid metabolites and vitamin D levels and colorectal cancer [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(06): 661-665.
[9]	Jian Chang, Feng Qiu, Yuqi Mao. Analysis of the relationship between ingestion inhibition factor-1 and liver metastasis after laparoscopic radical resection of colorectal cancer [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(05): 502-505.
[10]	Xiaoyan Wang, You Xiao, Ge Xiao, Zhenquan Wang. CT characteristics and risk factors of lung metastasis in elderly patients with colorectal cancer [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(05): 506-509.
[11]	Wenkai Ni, Chong Qi, Xiaodan Xu, Xiecheng Zhou, Qingzhang Yin, Yuankun Cai. Analysis of influencing factors of prolonged postoperative ileus in patients with colorectal cancer after operation [J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2023, 12(06): 484-489.
[12]	Xiaoyu Fan, Sizheng Sun, Yimin E, Chunzhao Yu. Different surgical options for obstructive left colon cancer [J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2023, 12(06): 500-504.
[13]	Xu Guan, Xishan Wang. Reflecting on the merits and demerits of regional lymph node management in colorectal cancer based on surgical and immune perspectives [J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2023, 12(06): 448-452.
[14]	Ruiqi Gu, Hongsheng Fang, Guoxiang Cai. Application and progress of circulating tumor DNA detection technology in the diagnosis and treatment of colorectal cancer [J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2023, 12(06): 453-459.
[15]	Wenyun Hou, Hengchang Liu, Lizhou Dou, Haipeng Chen, Zhaoxu Zheng, Guiqi Wang, Xishan Wang. A case of total laparoscopic radical surgery for right colon cancer with colonoscope-assisted transluminal extraction of specimen without auxiliary incision (ileocecal junction preservation) [J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2023, 12(05): 436-440.

Please choose a citation manager

Content to export